Ann: Company Presentation, page-9

I agree, I am pretty disappointed by this delay... In February Leedman said we were a matter of weeks away from starting Ph1 trials and here we are now at the end of October, with trials now pushed out into 2022. Perhaps the Quarterly will reveal what the latest delay is due to, but I doubt it.

I had hoped that with Paul coming on board failing to meet timelines would be a thing of the past but it seems that even with new management, its the same NSB...

Holding, but would like management to hit milestones in the future or communicate honest timelines.